Qi Liu, PhD, on NSCLC: Pneumonitis, Immunotherapy, and Chemotherapy

May 18, 2020 By The ASCO Post Staff

Qi Liu, PhD, of the U.S. Food and Drug Administration, discusses data that suggest that patients with advanced non–small cell lung cancer who had a past medical history of pneumonitis were more likely to experience treatment-associated pneumonitis in response to immune checkpoint inhibitors or chemotherapy (Abstract CT086).

Related Content